Synapse - Renata Panchal

Renata Panchal

Research Focus

Information Systems; Associate Director, CRIT Product Management

Recent additions – View all

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Journal Article

Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
Clinical Cancer Research (2014)

Fulltext@MSK | Save
Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
Meeting Abstract

Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save
Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy
Meeting Abstract

Correa, D. D.; Baser, R.; Beal, K.; Karimi, S.; DeAngelis, L.; Panageas, K.; Barradas, R.; Statucka, M.; Abrey, L.; Gutin, P.; more...
Neuro-Oncology (2011)

Fulltext@MSK | Save

Co-authors at MSK

4

Abrey
4

Beal
4

Correa
4

De Angelis
4

Gutin
4

Omuro
4

Panageas
3

Chan
3

Gavrilovic
3

Grommes
3

Hormigo
3

Kaley
3

Karimi
3

Lassman
3

Melling...
3

Nolan
3

Reiner
2

Baser
1

Brennan
1

Faivre
1

Huse
1

Pentsova
1

Sanchez
1

Statucka
1

Tabar
1

Zhang

Types of Work

Publications